Invesco’s PetMed Express PETS Stock Holding History

Invesco’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,078	Closed	-$90.6K	–	3830
2025 Q3	$90.6K	Sell	36,078 -37,005	-51%	-$114K	﹤0.01%	3692
2025 Q2	$243K	Sell	73,083 -41,784	-36%	-$149K	﹤0.01%	3455
2025 Q1	$481K	Sell	114,867 -33,946	-23%	-$154K	﹤0.01%	3162
2024 Q4	$717K	Sell	148,813 -958	-0.6%	-$4.49K	﹤0.01%	3058
2024 Q3	$551K	Buy	149,771 +648	+0.4%	+$2.29K	﹤0.01%	3194
2024 Q2	$604K	Sell	149,123 -26,443	-15%	-$113K	﹤0.01%	3195
2024 Q1	$841K	Buy	175,566 +124,194	+242%	+$722K	﹤0.01%	3075
2023 Q4	$388K	Buy	51,372 +1,219	+2%	+$10K	﹤0.01%	3340
2023 Q3	$514K	Buy	50,153 +136	+0.3%	+$1.68K	﹤0.01%	3188
2023 Q2	$690K	Sell	50,017 -69,206	-58%	-$1.04M	﹤0.01%	3077
2023 Q1	$1.94M	Buy	119,223 +25,166	+27%	+$474K	﹤0.01%	2647
2022 Q4	$1.66M	Buy	94,057 +15,768	+20%	+$313K	﹤0.01%	2717
2022 Q3	$1.53M	Sell	78,289 -2,480	-3%	-$52.6K	﹤0.01%	2748
2022 Q2	$1.61M	Buy	80,769 +8,015	+11%	+$179K	﹤0.01%	2790
2022 Q1	$1.88M	Buy	72,754 +2,143	+3%	+$55.6K	﹤0.01%	2807
2021 Q4	$1.78M	Sell	70,611 -18,089	-20%	-$501K	﹤0.01%	2839
2021 Q3	$2.38M	Sell	88,700 -25,197	-22%	-$726K	﹤0.01%	2736
2021 Q2	$3.63M	Sell	113,897 -930	-0.8%	-$29.5K	﹤0.01%	2593
2021 Q1	$4.04M	Buy	114,827 +10,573	+10%	+$368K	﹤0.01%	2467
2020 Q4	$3.34M	Buy	104,254 +24,947	+31%	+$769K	﹤0.01%	2389
2020 Q3	$2.51M	Sell	79,307 -18,188	-19%	-$602K	﹤0.01%	2380
2020 Q2	$3.47M	Buy	97,495 +8,906	+10%	+$309K	﹤0.01%	2194
2020 Q1	$2.55M	Sell	88,589 -13,939	-14%	-$365K	﹤0.01%	2261
2019 Q4	$2.41M	Buy	102,528 +4,891	+5%	+$110K	﹤0.01%	2568
2019 Q3	$1.76M	Buy	97,637 +38,736	+66%	+$640K	﹤0.01%	2707
2019 Q2	$923K	Sell	58,901 -36,890	-39%	-$726K	﹤0.01%	3114
2019 Q1	$2.18M	Buy	95,791 +42,328	+79%	+$954K	﹤0.01%	2557
2018 Q4	$1.24M	Sell	53,463 -69,042	-56%	-$1.84M	﹤0.01%	2847
2018 Q3	$4.04M	Buy	122,505 +3,060	+3%	+$114K	﹤0.01%	2280
2018 Q2	$5.26M	Sell	119,445 -87,947	-42%	-$3.41M	﹤0.01%	2105
2018 Q1	$8.66M	Buy	207,392 +46,725	+29%	+$2.16M	﹤0.01%	1636
2017 Q4	$7.31M	Sell	160,667 -81,883	-34%	-$3.23M	﹤0.01%	1761
2017 Q3	$8.04M	Sell	242,550 -171,673	-41%	-$6.99M	﹤0.01%	1695
2017 Q2	$16.8M	Sell	414,223 -31,900	-7%	-$988K	0.01%	1268
2017 Q1	$8.98M	Buy	446,123 +74,756	+20%	+$1.58M	﹤0.01%	1607
2016 Q4	$8.57M	Buy	371,367 +50,044	+16%	+$1.07M	﹤0.01%	1658
2016 Q3	$6.52M	Buy	321,323 +93,652	+41%	+$1.89M	﹤0.01%	1800
2016 Q2	$4.27M	Buy	227,671 +40,020	+21%	+$735K	﹤0.01%	2031
2016 Q1	$3.36M	Buy	187,651 +67,088	+56%	+$1.15M	﹤0.01%	2150
2015 Q4	$2.07M	Buy	120,563 +66,904	+125%	+$1.12M	﹤0.01%	2506
2015 Q3	$864K	Buy	53,659 +833	+2%	+$14K	﹤0.01%	3004
2015 Q2	$912K	Buy	52,826 +1,727	+3%	+$29K	﹤0.01%	3134
2015 Q1	$844K	Buy	51,099 +290	+0.6%	+$4.49K	﹤0.01%	3119
2014 Q4	$730K	Sell	50,809 -4,445	-8%	-$59.9K	﹤0.01%	3129
2014 Q3	$751K	Sell	55,254 -22	-0%	-$306	﹤0.01%	3132
2014 Q2	$745K	Sell	55,276 -71,668	-56%	-$946K	﹤0.01%	3176
2014 Q1	$1.7M	Sell	126,944 -34,476	-21%	-$478K	﹤0.01%	2695
2013 Q4	$2.68M	Buy	161,420 +6,871	+4%	+$107K	﹤0.01%	2469
2013 Q3	$2.52M	Buy	154,549 +25,260	+20%	+$394K	﹤0.01%	2374
2013 Q2	$1.63M	Buy	+129,289	New	+$1.69M	﹤0.01%	2524

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPH

Steel Partners Holdings New York $96.4M AUM

Invesco's PETS Position: Q4 2025 in Review

Invesco sold out of PetMed Express (PETS) in Q4 2025, closing a stake of 36,078 shares — an estimated $90.6K sold.

Invesco first reported a position in PETS in Q2 2013 and held it in 50 quarters. The position peaked at $16.8M in Q2 2017. 51 funds tracked by Wall St. Rank hold PETS as of Q4 2025.

Invesco reported no remaining PetMed Express position as of Q4 2025 after selling out during the quarter.
Invesco sold 36,078 PetMed Express shares in Q4 2025, an estimated $90.6K.
Invesco first reported a position in PetMed Express in Q2 2013 and held it in 50 quarters.
Invesco's PetMed Express position peaked at $16.8M in Q2 2017.
51 funds tracked by Wall St. Rank held PetMed Express as of Q4 2025.

Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.